TP53 and urinary bladder carcinoma: For instance, the combination of TP53 R273H and HLA-A02:01 is absent in existing bladder cancer patients but can be retrieved in the ‘Search’ page, which provides the predicted neoantigens generated by all combinations of recurrent TP53 mutations and highly frequent HLA alleles (Figure 2D).